Partnering With Antenatal Navigators to Transform Health in Pregnancy
Launched by NORTHWESTERN UNIVERSITY · Apr 19, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The PATH study, which stands for Partnering With Antenatal Navigators to Transform Health in Pregnancy, is designed to see if a special support program can improve the health of pregnant individuals and their babies. This program, called antenatal patient navigation, helps pregnant people access the healthcare services they need and addresses any challenges they might face. In this study, some pregnant individuals will receive this extra support, while others will continue with the usual care they receive. The goal is to find out if those with the navigation support have better health outcomes for themselves and their babies.
To participate in this study, you need to be a pregnant person who is less than 20 weeks along, is a first-time mother, and has a low income. You should also be able to read and speak either English or Spanish and be at least 16 years old. Participants will receive support from navigators throughout their pregnancy and for two weeks after giving birth. The study is not yet recruiting participants, but it aims to improve experiences for patients and healthcare providers, making sure that everyone gets the best care possible during this important time.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Singleton gestation \<20 weeks of gestation
- • Nulliparous: no prior pregnancies ≥20 weeks excluding terminations
- • Low income: public insurance or residence in a neighborhood in which \>10% of household incomes are \<200% of federal poverty line
- • Ability to speak and read English or Spanish
- • Established patient at one of practices associated with Northwestern Medical Group
- • Age 16 years or older
- Exclusion:
- • Intent to transfer care to an outside institution
- • Prior enrollment in PATH
- • Concurrent enrollment in a study with competing aims/intervention
About Northwestern University
Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Lynn M Yee, MD, MPH
Principal Investigator
Northwestern University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported